Honeywell

The webinar will address considerations when evaluating oligonucleotide synthesis reagent and solvent suppliers. Topics include scaling production during a global crisis; accessing manufacturing resources on multiple continents; and transitioning from glass to returnable containers to save space, cost, and time, while being environmentally conscious.

https://www.pharmtech.com/pt_w/oligonucleotide-synthesis-solutions

Join us for an in-depth webinar that will explore what global contract development and manufacturing organizations (CDMOs) and commercial life science pharmaceutical organizations in the oligonucleotide synthesis space look for when evaluating primary and secondary suppliers of high-purity reagents and solvents in light of the recent pandemic. This webinar provides an overview of the key considerations for supporting oligonucleotide synthesis across various contexts, with a special focus on the latest advancements in sulfurization reagents and water determination techniques.

Why a global manufacturing footprint is as critical as having batch-to-batch consistency.

What to look for when evaluating suppliers to produce custom blends of reagents and solvents in varying batch sizes.

What can be gained by transitioning your solvents and reagents from glass to returnable containers.

Is access to a regional expert adequate when scaling to production during a global crisis?

What are the challenges associated with sulfurization reagents for oligonucleotide synthesis and what’s the risk of limited access to technical experts?


This webinar is ideal for professionals involved in oligonucleotide synthesis, including researchers, laboratory managers, and product development specialists, who are looking to enhance the stability and efficiency of their oligo synthesis processes and supply chain. This webinar is open to professionals with roles supporting:

Organizations that perform or require solvents and reagents for:


R&D Manager, Research Chemicals
Honeywell

Stefan Seekamp, PhD, studied chemistry at the Leibniz University Hannover in Hanover, Germany, with a focus on analytical chemistry. Dr Seekamp completed his dissertation on the topic of method development for low-intermediate radioactive waste at the Jülich Research Centre in Jülich, Germany. He held a postdoctoral position at the Argonne National Laboratory in Lemont, Illinois, in the United States. Dr Seekamp has held a wide range of positions with Honeywell since 2002 and is currently the global R&D leader for Honeywell Research Chemicals.




Director, Strategic Accounts Management
Honeywell

Marc Lorain studied biology at the Lyon I University with a focus on agronomy.
Lorain began his career as a sales representative for a regional distributor in France and then held sales management positions for leading international chemical and biological reagent companies. He joined Honeywell in 2016 as the global sales leader for research chemicals. Currently, he is director of strategic accounts management and oversees the life sciences and pharmaceutical markets for EMEA.

Webcasts

Webinar Date/Time: Thu, Oct 24, 2024 10:00 AM EDT


Global Considerations for Oligonucleotide Synthesis Solutions

Honeywell and the Future of Life Sciences Manufacturing

To learn more about manufacturing in the life sciences industry, 

sat down with Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, at a recent INTERPHEX conference to discuss:

How automation technologies will likely evolve;

How Honeywell helps meet current industry challenges while maintaining an eye on the future;

What differentiates Honeywell from the competition in its approach to manufacturing and digitalization.

Videos

Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, discusses how the company stands out in an industry that constantly evolves. 


Honeywell and the Future of Life Sciences Manufacturing 

Articles

This on-demand webinar shows how to connect unintegrated equipment to achieve real-time visibility across production, centralized recipe management, and batch reporting.


Orchestration for Distributed Batch Management

Bring vaccines and therapies to market faster through earlier production control planning, standard pre-structured automation designs, and advanced technology.  

Fast Track Automation for Life Sciences

http://promo.mjhlifesciences.com/biopharmacongress/

The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal.

This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry.

Adare, Aizon, BASF, Beckman Coulter, Catalent, DocuSign, Honeywell, Lighthouse, Lonza Pharma and Biotech, LSNE, Mikart, Nelson Labs, Qualicaps, Shimadzu, suez and VAI

Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT

On demand available after airing until Nov. 11, 2021.

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021

2020 Bio/Pharma Virtual Congress

Learn practical tips to improve cybersecurity in your facility to protect workers, processes, and ultimately the patients that depend on your product.
